InnoSkel

French tech company | Builders Republic

About

Platform biotech developing gene therapies for rare skeletal disorders caused by type II collagen mutations — from spondyloepiphyseal dysplasia congenita (SEDc) to other collagenopathies — using proprietary gene therapy assets advancing through observational studies and regulatory pathways (UK MHRA Innovation Passport).

Key facts

Status
Morte
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2020
City
BIOT
Region
Provence-Alpes-Côte d’Azur
Tracked rounds
1
Amount raised
20 M€ raised since 2020

Funding rounds

  • Series A — 2020

Investors